DHM (Dihydromyricetin): Benefits, Dosage, Safety & Guide

Quick Facts

What Is DHM?

Dihydromyricetin (DHM), also known by the chemical name ampelopsin, is a naturally occurring flavonoid extracted from Ampelopsis grossedentata (vine tea) and Hovenia dulcis (Japanese raisin tree). The compound has been used in traditional Chinese medicine for centuries under the common name “vine tea” or “teng cha,” with historical applications including treatment of fever, cough, jaundice, and alcohol-related discomfort. The Ampelopsis grossedentata plant grows natively in humid subtropical regions of southern China, where dried vine tea preparations have been consumed as a beverage for generations.

Chemically, DHM belongs to the flavanonol subclass of flavonoids and carries a characteristic molecular structure with multiple hydroxyl groups that confer strong antioxidant capacity. Flavonoids as a class are among the most widely studied plant compounds, and DHM occupies a specific niche within this group because of its reported effects on alcohol metabolism and liver function — benefits that distinguish dihydromyricetin from most other dietary flavonoids.

DHM is now marketed globally as a supplement for hangover prevention and liver health. The compound’s growing commercial presence reflects genuine scientific interest: research groups across China, the United States, and Europe have published preclinical studies examining DHM’s effects on liver enzymes, oxidative stress markers, GABA receptor function, and neuroprotection. Human clinical data remains sparse, which places DHM appropriately in the “B” evidence tier — promising mechanisms backed by animal and in vitro studies, with human confirmation still forthcoming.

How DHM Works

DHM exerts biological effects through several overlapping mechanisms, each supported by preclinical research. Understanding these pathways helps explain why the compound attracts interest for alcohol metabolism and liver protection specifically.

Alcohol metabolism enzyme support. The liver metabolizes ethanol in two sequential steps. First, alcohol dehydrogenase (ADH) converts ethanol into acetaldehyde. Second, acetaldehyde dehydrogenase (ALDH) converts acetaldehyde into acetate, a relatively harmless metabolite. Acetaldehyde — not ethanol itself — is responsible for most of the toxic effects of alcohol consumption, including liver inflammation, headache, and nausea. Animal and in vitro research indicates that DHM upregulates both ADH and ALDH activity, potentially accelerating clearance of acetaldehyde from the liver and bloodstream. A 2025 study in Phytomedicine (Ma et al., PMID: 39986231) demonstrated that DHM at 75–150 mg/kg/day significantly reduced ALT/AST abnormalities and liver steatosis in alcohol-fed mice, in part through modulation of the miR-155-5p/SIRT1 signaling pathway.

GABA-A receptor modulation. Ethanol exerts much of its intoxicating effect by enhancing GABA-A receptor activity in the brain, producing sedation and disinhibition. DHM appears to interact with the benzodiazepine binding site on the GABA-A receptor, potentially normalizing receptor function that has been altered by alcohol. Research by Getachew et al. (2022, PMID: 35386023) demonstrated that DHM completely prevented ethanol-induced cell toxicity in neuronal SH-SY5Y cells, with this protection blocked by flumazenil (a GABA-A antagonist), implicating the benzodiazepine receptor site as the mechanism of action.

Nrf2/HO-1 antioxidant pathway activation. DHM activates the Nrf2-Keap1 pathway, a master regulator of cellular antioxidant defenses. Nrf2 activation increases the expression of antioxidant enzymes including heme oxygenase-1 (HO-1), superoxide dismutase, and glutathione peroxidase. This pathway is particularly relevant in the liver during alcohol metabolism, where the production of reactive oxygen species (ROS) is high. Activation of Nrf2 by DHM effectively supports the liver’s own antioxidant response.

Anti-inflammatory activity. DHM inhibits NF-κB signaling, one of the primary inflammatory transcription pathways. Reduced NF-κB activity results in lower expression of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β. This anti-inflammatory mechanism is relevant for alcohol-related liver inflammation and may contribute to DHM’s broader tissue-protective effects documented in preclinical models.

Benefits of DHM

Does DHM support liver health and protect against alcohol-induced damage?

Animal research shows DHM reduces liver damage markers in alcohol-fed models — a 2025 study in Phytomedicine (Ma et al., PMID: 39986231) found DHM administration at 75–150 mg/kg/day for 7 weeks significantly reduced ALT and AST abnormalities, decreased hepatic inflammation, and reduced liver steatosis in mice fed the Lieber-DeCarli alcohol liquid diet. The liver accumulates approximately 90% of consumed alcohol for metabolism, making hepatic tissue highly vulnerable to ethanol-derived oxidative stress. DHM appears to support liver health through three parallel mechanisms. First, DHM upregulates ADH and ALDH enzyme activity, accelerating metabolism of both ethanol and its toxic intermediate acetaldehyde. Second, Nrf2 pathway activation by DHM increases production of glutathione and other endogenous antioxidants that neutralize reactive oxygen species generated during alcohol processing. Third, NF-κB inhibition by DHM reduces the inflammatory response that typically accompanies repeated alcohol exposure. A 2024 review in Frontiers in Pharmacology (He et al., PMID: 38650630) comprehensively described how Hovenia dulcis-derived compounds including DHM affect ALD through multiple pathways, including ethanol metabolism, immune response, hepatic fibrosis, oxidative stress, and intestinal barrier function — an unusually broad mechanistic profile for a single plant compound.

Does DHM reduce hangover symptoms?

DHM is most widely marketed for hangover prevention, with mechanistic rationale centered on acetaldehyde clearance — elevated acetaldehyde accounts for the majority of common hangover symptoms including headache, nausea, and fatigue. Research consistently shows that effectiveness for hangover support is greatest when DHM is taken before or during alcohol consumption rather than after. The mechanism depends on priming liver enzyme activity before acetaldehyde accumulates rather than clearing established toxic metabolite loads. DHM taken 30–60 minutes before drinking may support faster acetaldehyde processing throughout the drinking period, blunting peak acetaldehyde levels that would otherwise drive hangover symptoms. General supplemental dosing guidance places the effective range at 300–600 mg, adjusted for body weight — approximately 300 mg for individuals under 60 kg, 500 mg for those between 60–80 kg, and 600 mg for those over 80 kg. Human clinical trials specifically measuring hangover symptom reduction with DHM remain limited, and mechanistic plausibility should not be overstated as clinical proof.

Does DHM provide antioxidant protection?

DHM demonstrates antioxidant activity through two distinct mechanisms: direct free radical scavenging and indirect enhancement of endogenous antioxidant systems. A broad 2017 review in Evidence-Based Complementary and Alternative Medicine (Li et al., PMID: 28947908) summarized DHM’s multiple pharmacological activities and specifically noted that DHM “may scavenge ROS to protect against oxidative stress.” The multiple hydroxyl groups on DHM’s flavonoid structure allow the molecule to directly donate electrons to reactive oxygen species, neutralizing approximately 60–70% of the hydroxyl radical activity measured in in vitro assays. DHM also activates the Nrf2-Keap1 pathway, which functions as a cellular stress sensor. When Nrf2 is activated, it translocates to the nucleus and upregulates transcription of antioxidant response genes including HO-1, NQO1, and glutamate-cysteine ligase — the rate-limiting enzyme in glutathione synthesis. This dual action positions DHM as a compound that both directly neutralizes oxidative damage and systemically enhances the liver’s antioxidant capacity.

Does DHM support neuroprotection?

Preclinical evidence suggests DHM may protect neurons from oxidative and inflammatory damage, particularly in the context of alcohol neurotoxicity and age-related neurodegeneration. Research by Getachew et al. (2023, PMID: 36585544) demonstrated that DHM protected dopaminergic SH-SY5Y cells from salsolinol-induced toxicity — a relevant model for Parkinson’s disease research. The protection was mediated through GABA-A receptor signaling and was synergistic with butyrate co-administration. A separate study by the same group (2022, PMID: 35386023) showed DHM completely prevented ethanol-induced cell death in the same neuronal cell line. These findings position DHM as potentially neuroprotective via GABA-A modulation and antioxidant mechanisms. It is important to note that neuroprotection data for DHM is entirely preclinical at this stage. Animal and cell-line findings should not be extrapolated to prevention or treatment of human neurodegenerative diseases, and DHM should not be characterized as a treatment for any neurological condition.

Does DHM have anti-inflammatory effects?

DHM reduces inflammatory marker expression in multiple preclinical models through NF-κB pathway inhibition. NF-κB is a transcription factor that controls the expression of dozens of pro-inflammatory genes, and its chronic activation is associated with liver disease, metabolic syndrome, and inflammatory conditions. DHM’s ability to suppress NF-κB signaling has been documented in liver, cancer, and gut inflammation models. A 2021 study in Pharmacological Research (Dong et al., PMID: 34273490) found DHM significantly improved DSS-induced colitis in mice through modulation of gut microbiota and bile acid metabolism, with downstream effects including reduced colonic inflammation and improved gut barrier integrity. DHM also enriched beneficial gut bacteria including Lactobacillus and Akkermansia. While these findings are from animal models, the multi-pathway anti-inflammatory action of DHM — NF-κB suppression, gut microbiome modulation, and bile acid receptor activation — suggests a compound with systemic anti-inflammatory potential beyond the liver specifically.

What is DHM’s bioavailability and how does formulation affect absorption?

DHM’s oral bioavailability is approximately 4% in animal models — a genuinely low figure driven by the compound’s poor water solubility, limited membrane permeability, and susceptibility to intestinal degradation. This pharmacokinetic limitation is scientifically important and often overlooked in supplement marketing. At 4% bioavailability, a 500 mg dose delivers roughly 20 mg of systemically absorbed DHM. Researchers have investigated multiple strategies to improve DHM absorption: chitosan nanoencapsulation has shown promise in animal studies for improving bioavailability and preserving antioxidant activity; solid lipid nanoparticles, liposomal delivery, and crystallization inhibitor co-formulations have also been studied. The 60% ethanol / 180-minute / 60°C extraction method has been identified as optimizing DHM yield from vine tea leaves, relevant for standardizing supplement raw material quality. When selecting a DHM supplement, bioavailability-enhancing delivery systems are worth considering — though few commercial products have published human pharmacokinetic data demonstrating meaningful absorption improvements over standard powder preparations.

What is the optimal DHM dosage?

Standard Dose for Alcohol Support

The most commonly cited dose for alcohol metabolism support is 300–600 mg taken 30–60 minutes before drinking. This weight-adjusted approach appears in both research discussions and commercial product guidelines:

• Under 60 kg (130 lb): 300 mg
• 60–80 kg (130–180 lb): 500 mg
• Over 80 kg (180 lb): 600 mg

These dose ranges are empirically derived from supplement practice and manufacturer guidance rather than formal human dose-response clinical trials. Do not exceed 1,000 mg in a single day. Taking DHM after drinking may provide some benefit but timing evidence supports pre-drinking administration as more effective.

Daily Supplementation

For general antioxidant and liver support purposes, 300–600 mg daily taken with meals is the typical recommendation. Daily dosing allows the antioxidant and anti-inflammatory mechanisms to operate continuously rather than acutely.

Timing

DHM is most effective for alcohol support when taken 30–60 minutes before consumption, allowing liver enzyme activity to be primed before acetaldehyde accumulates. For general health purposes, DHM can be taken at any consistent daily time. No loading phase is required.

Is DHM safe?

DHM has a strong safety record in both traditional use and short-term supplementation contexts. The NIH LiverTox database (PMID: 37643278) specifically notes that “dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice” — a reassuring finding given that the liver is the primary metabolic site for DHM.

General Safety Profile

Short-term animal studies have shown no adverse effects even at elevated doses. Reported side effects in human users are infrequent and generally mild, including occasional digestive discomfort (nausea, stomach cramps, diarrhea) and drowsiness. These effects appear most common at higher doses or on an empty stomach.

Drug Interactions

DHM may influence cytochrome P450 liver enzyme activity, which is relevant for individuals taking prescription medications that are metabolized by the same enzyme system. This potential interaction is theoretical rather than well-documented in human studies, but individuals taking prescription medications should consult a healthcare provider before adding DHM supplementation.

Contraindications

DHM is not recommended during pregnancy or breastfeeding due to insufficient safety data. Individuals with alcohol use disorder or liver disease should consult a physician before using DHM. DHM interacts with GABA-A receptors, which is the same system targeted by benzodiazepine medications — theoretical interactions in individuals taking benzodiazepines warrant medical guidance.

Long-Term Safety

Long-term human safety data is not available. The compound has been consumed in traditional tea preparations in Asian populations for generations with no documented population-level harms, but formal long-term clinical safety studies have not been conducted in supplement doses.

Frequently Asked Questions

Can I take DHM after drinking to reduce hangovers?

DHM taken after drinking may offer some benefit, but research and mechanistic rationale support pre-drinking administration as significantly more effective. Acetaldehyde accumulates rapidly during alcohol consumption — priming liver enzymes before drinking begins is more likely to reduce peak acetaldehyde levels than attempting to clear an established acetaldehyde load afterward. If taken after drinking, taking DHM as soon as possible (rather than the following morning) is the better approach.

Does DHM sober you up?

DHM does not act as an acute sobriety agent. The GABA-A receptor modulation mechanism may blunt some subjective intoxication effects, but DHM does not meaningfully accelerate blood alcohol clearance to a degree that would make an intoxicated person safe to drive or operate machinery. DHM supports metabolic processing of alcohol’s byproducts — it does not neutralize alcohol itself.

Can I take DHM every day?

Daily supplementation at 300–600 mg appears safe based on available evidence, though formal long-term human safety studies are not available. Many users take DHM daily for general liver and antioxidant support rather than solely for alcohol-related occasions.

Does DHM interact with medications?

Potential CYP enzyme interactions and GABA-A receptor modulation are the two main interaction concerns. Individuals taking benzodiazepines, barbiturates, or other CNS depressants should consult a healthcare provider before use. Those on medications metabolized by the liver’s CYP3A4, CYP2C9, or CYP2D6 enzyme systems should also seek medical guidance.

What does DHM taste like?

Pure DHM powder has a slightly bitter, mildly astringent flavor characteristic of flavonoids. Vine tea (the traditional preparation) is commonly described as having a pleasant sweetness that develops as DHM is metabolized. Most supplement users consume DHM in capsule form to avoid the taste.

Source in Bulk

Looking to source bulk DHM (dihydromyricetin) powder for manufacturing or formulation? WHYZ supplies wholesale quantities with COA documentation and free evaluation samples. Request a quote →

References

1. Ma Q, Huang S, Li MY, et al. Dihydromyricetin regulates the miR-155-5p/SIRT1/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury. Phytomedicine. 2025;139:156522. doi:10.1016/j.phymed.2025.156522. PMID: 39986231

2. He YX, Liu MN, Wang YY, et al. Hovenia dulcis: a Chinese medicine that plays an essential role in alcohol-associated liver disease. Front Pharmacol. 2024;15:1337633. doi:10.3389/fphar.2024.1337633. PMID: 38650630

3. Getachew B, Csoka AB, Tizabi Y. Dihydromyricetin Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line: Role of GABA(A) Receptor. Neurotox Res. 2022;40(3):892-899. doi:10.1007/s12640-022-00503-9. PMID: 35386023

4. Getachew B, Csoka AB, Copeland RL, Manaye KF, Tizabi Y. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson’s Disease. Neurotox Res. 2023;41(2):141-148. doi:10.1007/s12640-022-00631-2. PMID: 36585544

5. Li H, Li Q, Liu Z, et al. The Versatile Effects of Dihydromyricetin in Health. Evid Based Complement Alternat Med. 2017;2017:1053617. doi:10.1155/2017/1053617. PMID: 28947908

6. Dong S, Zhu M, Wang K, et al. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Pharmacol Res. 2021;171:105767. doi:10.1016/j.phrs.2021.105767. PMID: 34273490

7. Dihydromyricetin. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): NIDDK; 2023 Aug 16. PMID: 37643278